Overall Status

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Multitude Therapeutics Inc. (1)

Regeneron Pharmaceuticals (1)

Collaborator

Sanofi (1)

Tigermed Consulting Co., Ltd (1)

Intervention

aflibercept (1)

amt-151 (1)

cisplatin (1)

pemetrexed (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

advanced carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting

Advanced Solid Tumor
+18 more

AMT-151

(no location specified)

Aug 10, 2022

Advanced Carcinoma, NSCLC Trial in Canada, United States (Aflibercept, Pemetrexed, Cisplatin)

Terminated

Advanced Carcinoma
Non-small Cell Lung Cancer

Aflibercept
+2 more

Tucson, Arizona
+14 more

Nov 13, 2020